Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $42.01 million. The enterprise value is $46.33 million.
Important Dates
The next estimated earnings date is Friday, May 15, 2026, after market close.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 3.56 million shares outstanding. The number of shares has increased by 80.51% in one year.
| Current Share Class | 3.56M |
| Shares Outstanding | 3.56M |
| Shares Change (YoY) | +80.51% |
| Shares Change (QoQ) | +22.55% |
| Owned by Insiders (%) | 23.69% |
| Owned by Institutions (%) | 7.36% |
| Float | 2.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.63 |
| Forward PS | 1.81 |
| PB Ratio | 20.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.55 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.83 |
Financial Efficiency
Return on equity (ROE) is -170.24% and return on invested capital (ROIC) is -65.02%.
| Return on Equity (ROE) | -170.24% |
| Return on Assets (ROA) | -39.26% |
| Return on Invested Capital (ROIC) | -65.02% |
| Return on Capital Employed (ROCE) | -139.49% |
| Weighted Average Cost of Capital (WACC) | 8.38% |
| Revenue Per Employee | $210,273 |
| Profits Per Employee | -$289,364 |
| Employee Count | 55 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.82% in the last 52 weeks. The beta is 0.78, so EKSO's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +65.82% |
| 50-Day Moving Average | 10.64 |
| 200-Day Moving Average | 6.79 |
| Relative Strength Index (RSI) | 60.13 |
| Average Volume (20 Days) | 55,574 |
Short Selling Information
The latest short interest is 215,103, so 6.04% of the outstanding shares have been sold short.
| Short Interest | 215,103 |
| Short Previous Month | 196,901 |
| Short % of Shares Out | 6.04% |
| Short % of Float | 9.61% |
| Short Ratio (days to cover) | 3.28 |
Income Statement
In the last 12 months, EKSO had revenue of $11.57 million and -$15.92 million in losses. Loss per share was -$5.56.
| Revenue | 11.57M |
| Gross Profit | 6.11M |
| Operating Income | -14.75M |
| Pretax Income | -15.69M |
| Net Income | -15.92M |
| EBITDA | -13.11M |
| EBIT | -14.75M |
| Loss Per Share | -$5.56 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 4.32M |
| Net Cash | -4.32M |
| Net Cash Per Share | -$1.21 |
| Equity (Book Value) | 5.74M |
| Book Value Per Share | 0.59 |
| Working Capital | 4.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.96 million and capital expenditures -$178,000, giving a free cash flow of -$11.99 million.
| Operating Cash Flow | -11.96M |
| Capital Expenditures | -178,000 |
| Depreciation & Amortization | 1.57M |
| Net Borrowing | -1.33M |
| Free Cash Flow | -11.99M |
| FCF Per Share | -$3.36 |
Full Cash Flow StatementMargins
Gross margin is 52.86%, with operating and profit margins of -127.57% and -135.66%.
| Gross Margin | 52.86% |
| Operating Margin | -127.57% |
| Pretax Margin | -135.66% |
| Profit Margin | -135.66% |
| EBITDA Margin | -113.32% |
| EBIT Margin | -127.57% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.51% |
| Shareholder Yield | -80.51% |
| Earnings Yield | -37.88% |
| FCF Yield | -28.54% |
Analyst Forecast
The average price target for EKSO is $9.50, which is -19.42% lower than the current price. The consensus rating is "Buy".
| Price Target | $9.50 |
| Price Target Difference | -19.42% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
